TB31F

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameTB31F
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-pfs48/45
Targetspfs48-45 protein
Therapy Area/IndicationsMalaria, Falciparum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsMali
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRadboud University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Medical Center
Inactive CompaniesN/A
Active IndicationsMalaria, Falciparum
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A